Jiangsu Hualan Stock Soars 6.51%, Hits Intraday High of CNY 91.99

Jiangsu Hualan New Pharmaceutical Material Co., Ltd. has experienced a significant uptick in its stock performance, gaining 6.51% on March 18, 2026. The stock reached an intraday high of CNY 91.99, showcasing its notable activity in the market. In terms of performance metrics, Jiangsu Hualan has outperformed the China Shanghai Composite index, which recorded a modest increase of 0.32% on the same day. Over the past week, the company’s stock rose by 5.88%, while the index declined by 1.7%. The one-month performance reflects a robust increase of 13.39%, contrasting with the index's slight decrease of 0.47%. Looking at longer-term trends, Jiangsu Hualan has shown remarkable growth over the past year, with a staggering 289.61% increase, significantly surpassing the China Shanghai Composite's 18.46% rise. Year-to-date, the stock has gained 76.13%, while the index has only increased by 2.37%. Despite these gains, the company faces challenges, including low management efficiency and declining net sales over the past five years.